Sentieon provides scientists, clinicians, patients and consumers with accurate genomic information for precision medicine. Sentieon’s proprietary technology brings unprecedented cycle time, accuracy and precision to the bioinformatics market. The Sentieon analytics tool recently was awarded the 2016 Top Overall Performance Award by FDA Commissioner Dr. Robert Califf (https://precision.fda.gov/challenges/consistency/results).
Sentieon’s product roadmap includes distinguishing malignant tumors from benign tumors for cancer diagnostics and other unsolved problems in the burgeoning genomics industry.
CEO: Jun Ye
Company Headquarters: Mountain View, CA